文献速递肝病

依诺沙星上调miRNA生成并下调自身免疫性胆管炎中细胞毒性CD8 T细胞功能

Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis.
PubMed 文献 · Hepatology · 2021-08-10

在dnTGFβRII小鼠PBC模型中,肝浸润CD8 T细胞miRNA生成分子P4HA1和Ago2显著降低,颗粒酶B和穿孔素显著升高。依诺沙星治疗显著上调CD8 T细胞miRNA,有效治疗自身免疫性胆管炎,直接改变T细胞功能并降低Runx3和穿孔素表达。结论:依诺沙星通过增加miRNA表达降低CD8 T细胞致病性,阻止自身免疫性胆管疾病进展。

要点

  • dnTGFβRII小鼠CD8 T细胞miRNA生成分子P4HA1和Ago2降低,颗粒酶B和穿孔素升高。
  • 依诺沙星上调CD8 T细胞miRNA,有效治疗小鼠自身免疫性胆管炎。
  • 依诺沙星降低CD8 T细胞Runx3及穿孔素表达,减少干扰素-γ产生和增殖。

核心结论

  • 依诺沙星增加dnTGFβRII CD8 T细胞miRNA表达,降低CD8 T细胞致病性,有效阻止自身免疫性胆管疾病进展。

研究设计与样本

  • 研究使用dnTGFβRII小鼠模型,该模型中自身反应性CD8 T细胞发挥主要致病作用并显示miRNA下调模式。

主要发现

  • 肝浸润dnTGFβRII CD8 T细胞中miRNA生成分子P4HA1和Ago2水平显著降低,颗粒酶B和穿孔素水平显著升高。
  • 依诺沙星治疗显著上调dnTGFβRII CD8 T细胞miRNA,并有效治疗dnTGFβRII小鼠自身免疫性胆管炎。
  • 依诺沙星在离体和体外直接改变T细胞,导致记忆亚群数量改变、增殖减少和干扰素-γ产生减少。
  • 依诺沙星显著降低CD8 T细胞转录因子Runx3表达,并在mRNA和蛋白水平显著降低穿孔素表达。

临床怎么用

  • 靶向miRNA通路可纠正自身反应性T细胞中的病理性miRNA异常,为自身免疫性疾病提供治疗思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Primary biliary cholangitis (PBC) is a prototypical organ-specific autoimmune disease that is mediated by autoreactive T-cell attack and destruction of cholangiocytes. Despite the clear role of autoimmunity in PBC, immune-directed therapies have failed to halt PBC, including biologic therapies effective in other autoimmune diseases. MicroRNA (miRNA) dysregulation is implicated in the pathogenesis (PBC). In the dominant-negative TGF-β receptor type II (dnTGFβRII) mouse model of PBC, autoreactive CD8 T cells play a major pathogenic role and demonstrate a striking pattern of miRNA down-regulation. Enoxacin is a small molecule fluoroquinolone that enhances miRNA biogenesis, partly by stabilizing the interaction of transactivation response RNA-binding protein with Argonaute (Ago) 2. APPROACH AND RESULTS: We hypothesized that correcting aberrant T-cell miRNA expression with enoxacin in dnTGFβRII mice could modulate autoreactive T-cell function and prevent PBC. Here, we show that liver-infiltrating dnTGFβRII CD8 T cells have significantly decreased levels of the miRNA biogenesis molecules prolyl 4-hydroxylase subunit alpha 1 (P4HA1) and Ago2 along with significantly increased levels of granzyme B and perforin. Enoxacin treatment significantly up-regulated miRNAs in dnTGFβRII CD8 T cells and effectively treated autoimmune cholangitis in dnTGFβRII mice. Enoxacin treatment directly altered T cells both ex vivo and in vitro, resulting in altered memory subset numbers, decreased proliferation, and decreased interferon-γ production. Enoxacin significantly decreased CD8 T-cell expression of the transcription factor, Runx3, and significantly decreased perforin expression at both the mRNA and protein levels. CONCLUSIONS: Enoxacin increases miRNA expression in dnTGFβRII CD8 T cells, reduces CD8 T-cell pathogenicity, and effectively halted progression of autoimmune biliary disease. Targeting the miRNA pathway is a therapeutic approach to autoimmunity that corrects pathological miRNA abnormalities in autoreactive T cells.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Itoh A, Adams D, Huang W, et al. Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis. Hepatology. 2021. PMID: 33462854. doi:10.1002/hep.31724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。